DeepCure Selects First AI-Generated Drug Candidate, DC-9476, for Clinical Trials
Key Highlights DeepCure selects DC-9476, a novel BRD inhibitor, as its first development candidate. DC-9476 targets multiple autoimmune…
Browsing Tag
MIT
2 posts
Amide Technologies Appoints Dr. Brad Pentelute as New CEO
Key Highlights Dr. Brad Pentelute appointed as new CEO of Amide Technologies. Focus on scaling operations, enhancing product…